Rozov Yadin — SEC insider filings
SEC reporting owner CIK 1921268. 30 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 30 filings on record, filed 2022-05-03 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 5 filings — 273,741 shares, $1,695,516 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 17 legs across 4 filings — 129,886 shares, $7,043,234 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
- Largest priced transaction: sale of 105,000 shares @ $18.11 ($1,901,949) in Core Scientific, Inc./tx, filed 2024-11-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dave Inc./DE (DAVE) | Director | 11 | 2 legs · 13,741 sh · $112,608 | 16 legs · 24,886 sh · $5,141,285 | 7 |
| Core Scientific, Inc./tx (CORZ) | Director | 11 | 2 legs · 190,000 sh · $1,441,338 | 1 leg · 105,000 sh · $1,901,949 | 12 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | Director | 5 | 2 legs · 70,000 sh · $141,570 | — | 6 |
| MIDWEST HOLDING INC. (MDWT) | Director | 3 | — | — | 4 |
Insider filings — Rozov Yadin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Core Scientific, Inc./tx (CORZ) | Option exercise/expiry (X): 30,000 @ $6.81 · Option exercise/expiry (X): 30,000 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | Dave Inc./DE (DAVE) | Gift (G): 2,200 @ $0 | EDGAR |
| 2026-06-04 | 4 | Dave Inc./DE (DAVE) | Grant/award (A): 637 @ $0 | EDGAR |
| 2026-02-06 | 4 | Core Scientific, Inc./tx (CORZ) | Grant/award (A): 18,575 @ $0 | EDGAR |
| 2026-01-02 | 4 | Core Scientific, Inc./tx (CORZ) | Gift (G): 40,100 @ $0 | EDGAR |
| 2025-11-13 | 4 | Core Scientific, Inc./tx (CORZ) | Purchase (P): 30,000 (derivative) @ $9.95 | EDGAR |
| 2025-09-12 | 4 | Dave Inc./DE (DAVE) | Sale (S): 3 @ $225.21 · Sale (S): 848 @ $226.80 · Sale (S): 2,462 @ $227.90 · Sale (S): 822 @ $228.64 · Sale (S): 591 @ $229.75 | EDGAR |
| 2025-09-05 | 4 | Dave Inc./DE (DAVE) | Sale (S): 1,659 @ $195.79 · Sale (S): 1,012 @ $196.94 · Sale (S): 800 @ $197.95 · Sale (S): 3,035 @ $198.98 · Sale (S): 3,619 @ $199.90 · Sale (S): 2,327 @ $201.10 · +3 more | EDGAR |
| 2025-06-11 | 4 | Dave Inc./DE (DAVE) | Gift (G): 2,200 @ $0 · Gift (G): 2,200 @ $0 | EDGAR |
| 2025-06-06 | 4 | Dave Inc./DE (DAVE) | Grant/award (A): 1,105 @ $0 | EDGAR |
| 2025-06-05 | 4 | Dave Inc./DE (DAVE) | Sale (S): 5,400 @ $206.92 · Sale (S): 100 @ $207.79 | EDGAR |
| 2025-05-29 | 4 | Core Scientific, Inc./tx (CORZ) | Purchase (P): 110,000 @ $10.87 | EDGAR |
| 2025-01-28 | 4 | Core Scientific, Inc./tx (CORZ) | Grant/award (A): 20,448 @ $0 | EDGAR |
| 2024-11-22 | 4 | Core Scientific, Inc./tx (CORZ) | Sale (S): 105,000 @ $18.11 | EDGAR |
| 2024-11-12 | 4 | Core Scientific, Inc./tx (CORZ) | Option exercise/expiry (X): 195,000 @ $0.01 · Option exercise/expiry (X): 195,000 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Dave Inc./DE (DAVE) | Grant/award (A): 4,726 @ $0 | EDGAR |
| 2024-05-28 | 4 | Core Scientific, Inc./tx (CORZ) | Grant/award (A): 127,446 @ $0 · Grant/award (A): 47,793 @ $0 | EDGAR |
| 2024-05-15 | 4 | Core Scientific, Inc./tx (CORZ) | Purchase (P): 105,000 (derivative) @ $2.52 | EDGAR |
| 2024-03-18 | 4 | Core Scientific, Inc./tx (CORZ) | Purchase (P): 80,000 @ $3.07 · Purchase (P): 90,000 (derivative) @ $2.15 | EDGAR |
| 2024-03-11 | 4 | Dave Inc./DE (DAVE) | Purchase (P): 800 @ $37.31 | EDGAR |
| 2024-01-08 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 30,000 · Grant/award (A): 8,820 | EDGAR |
| 2023-12-21 | 4 | MIDWEST HOLDING INC. (MDWT) | Disposition to issuer (D): 22,661 @ $27 · Disposition to issuer (D): 1,164 @ $27 | EDGAR |
| 2023-12-06 | 4 | Dave Inc./DE (DAVE) | Purchase (P): 12,941 @ $6.40 | EDGAR |
| 2023-07-10 | 4 | Dave Inc./DE (DAVE) | Grant/award (A): 30,239 @ $0 | EDGAR |
| 2023-06-08 | 4 | MIDWEST HOLDING INC. (MDWT) | Grant/award (A): 1,164 @ $0 | EDGAR |
| 2023-04-20 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 30,000 | EDGAR |
| 2023-03-15 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Purchase (P): 20,000 @ $1.96 · Purchase (P): 50,000 @ $2.05 | EDGAR |
| 2022-08-01 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 12,000 | EDGAR |
| 2022-06-16 | 4 | MIDWEST HOLDING INC. (MDWT) | Grant/award (A): 2,674 @ $0 | EDGAR |
| 2022-05-03 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 4,500 · Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1921268 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs